Skip to content

Exercise Training on Health Outcomes in Scleroderma (ETHOS) Trial

Exercise as a therapeutic tool for the attenuation of physical function loss and change in health outcomes for people living with Systemic Sclerosis.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000987369
Acronym
ETHOS
Enrollment
28
Registered
2026-08-12
Start date
2027-03-01
Completion date
2037-03-02
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Current treatment strategies for SSc are targeted towards inflammation and pain relief, however they have a modest impact on addressing exertional intolerance, functional disability and their underlying physiology. On the other hand, there is a lack of defined evidence into other preventative non-pharmacological therapeutics such as exercise training in the clinical management of SSc. Due to its multifactorial effects on organ systems, exercise training has been proposed as an ideal adjunct strategy to address functional impairment, symptomatology and/or organ involvement in patients with SSc. However, the efficacy of exercise training in patients with SSc has primarily been explored in small pilot studies with safety-related or patient-reported endpoints. The impact of exercise to alter the physiologic factors that are contributing to symptom burden and morbidity in SSc has not received sufficient attention. Consequently, we want to evaluate whether a goal-directed exercise approach could be efficacious in addressing functional disability.

Interventions

This study will be investigating the efficacy of a 12-week supervised and personalised graded exercise training program in attenuating functional decline and improving health outcomes in systemic sclerosis (SSc) patients. The goal-directed exercise training program will consist of 30-60 minutes of supervised, aerobic and resistance training performed three times per week. Two sessions will be performed in-person in a gym-based setting, and one session will be performed remotely over telehealth.

This study will be investigating the efficacy of a 12-week supervised and personalised graded exercise training program in attenuating functional decline and improving health outcomes in systemic sclerosis (SSc) patients. The goal-directed exercise training program will consist of 30-60 minutes of supervised, aerobic and resistance training performed three times per week. Two sessions will be performed in-person in a gym-based setting, and one session will be performed remotely over telehealth. A multi-component exercise approach will be utilised to target the diverse pathophysiological processes that contribute to symptoms of exertional intolerance in individuals with SSc. This will include high-intensity interval training, moderate intensity continuous training, functional circuit training and progressive moderate-to-high intensity resistance training. The exercise prescription will be individualised to each participant's cardiopulmonary exercise test and muscle function assessments as well as their health and disease-specific factors. Exercise sessions will be prescribed and overseen by an Accredited Exercise Physiologist (AEP) and all training supervised by an appropriately trained AEP and/or Exercise Scientist. The program will consist of one week of familiarisation, and then two 5-week blocks incorporating a progressive increase in exercise duration and/or intensity (i.e progressive overload), which is followed by a de-load/recovery week. Session attendance will be logged and reminders sent out at least at least 24 hours prior to sessions. Aerobic Training Sessions: The aerobic component will consist of one continuous steady-state and two interval training session a week with all the sessions being completed on an upright cycle ergometer, with monitoring by the 1-10 rate of perceived exertion (RPE) for dyspnoea, and RPE 6-20 for effort, and/or smartwatches (with heart rate monitoring). For the telehealth session, participants will either use their own equipment (treadmill or cycle ergometer) or will work with the AEP to develop a moderate-intensity aerobic session that the participant can perform independently based on their goals and preferences such as walking outside. All sessions will include a 5-minute light-intensity aerobic warm-up and cool-down. The steady-state sessions will be completed from home with remote supervision via telehealth and will consist of 20-60 minutes of continuous cycling (not including the warm-up or cool-down) at a moderate intensity. The target heart rate for steady state sessions will be set at 5-15 beats/min below the heart rate corresponding to the ventilatory threshold or an RPE for effort of 12-14. The interval sessions will be performed in-person on a cycle ergometer or elliptical trainer, and will consist of 8-20 x alternating work intervals of 30-60 seconds at 80-100% of peak power output from the cardiopulmonary exercise test (CPET), interspersed with 30-90 seconds of unloaded cycling for recovery, and a longer recovery bout incorporated after every 4-5 intervals as required. Resistance Training Sessions: As part of the supervised training sessions, participants will complete six compound resistance exercises (three upper-body and three lower-body exercises) which will be centred around functional strength and endurance. Up to 3 sets of up to 15 repetitions will be utilised in the program which will include standard resistance exercises such as leg press, squats, lunges, step-ups, seated rows, chest-press, overhead shoulder press and lat pull-down. Exercise modifications will be made to accommodate participants with limited hand-grip strength and other mobility limitations. In the first 5-weeks of the program, participants will perform 1-3 sets of 12-15 repetitions that can be lifted before fatigue, along with a de-load/recovery week consisting of 1 set of each exercise. As part of the second 5-week block, participants will complete 2-3 sets of 6-12 repetitions until fatigue. Participants will be allowed to rest for 1-2 minutes between each set of exercise. Participants will be monitored using RPE scales, oxygen saturation, and HR throughout the session. The exercises performed in weeks 1-6 will be modified or changed slightly for weeks 7-12 for variety and progression purposes. For the home-based telehealth session, participants will instead perform a personalised circuit resistance session using exercises based on functional daily tasks such as sit-to-stand, incline push-ups, three-point rows and will consist of minimal equipment (mainly bodyweight and resistance bands).

Sponsors

St Vincent's Institute of Medical Research
Lead SponsorOther

Study design

Allocation
Randomised controlled trial
Intervention model
Other
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Males and females with a confirmed American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) classification of SSc • Aged 18+ years • Fluent in the English language

Exclusion criteria

• Absolute contraindication to exercise • Inability to cycle on an upright bike • Renal impairment (eGFR <30mL/min/1.73m2) • Pulmonary Arterial Hypertension • Current Atrial Fibrillation • Heart failure and/or LVEF <50% • Severe ILD defined as Forced Vital Capacity (FVC) <45% (predicted), single-breath carbon monoxide diffusing lung capacity (DLCO) corrected for haemoglobin <30% (predicted) • Contraindication to MRI (pacemaker, defibrillator or any implanted foreign body, severe claustrophobia) • Pregnancy or currently breastfeeding • Gadolinium allergy

Outcome results

None listed

Source: ANZCTR · Data processed: Aug 31, 2026